Linköping
18-75 years old
Patient studiesStudy 165
Do you or someone you care about suffer from migraines?
We are currently recruiting participants for a study investigating an oral study medication to understand if it could help in the treatment of migraines.
Target group: people with migraines, 18–75 years old
You may be able to participate in the study if:
- You are between 18 and 75 years old
- You had your first migraine before the age of 50
- You have had migraines for at least one year
- You experience an average of two to eight migraine episodes per month
- You have previously tried triptans, or cannot currently use triptans
The study will involve six visits to a clinical center and three phone calls over 24 weeks. This study involves taking a single dose of the oral study medication to treat each qualifying migraine attack for the entire duration of the study.
There is no cost to participate in the study. Participants may also receive compensation for travel expenses.
More information and registration
Would you like to participate in the study? Submit an expression of interest using the form below.
Do you have questions or want to know more? Call 018-30 33 99 or email info@ctc-ab.se.
The study is approved by the Swedish Ethical Review Authority and the Medical Products Agency. Your participation is voluntary, and you can withdraw at any time. The information you provide will be processed in accordance with the General Data Protection Regulation (GDPR).
